PARP1 and cancer: During aging, ROS levels increase, causing an increase in DNA damage.62 Therefore, there is an increase in PARP activity and the amount of NAD used as a substrate.119,120 Genetic or pharmacological inhibition of PARP1 prevents NAD decline during aging.121 However, PARP inhibition impedes DNA repair, increases DNA damage, and accelerates cancer initiation.